about
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?Advances in the understanding of the pathogenesis and epidemiology of herpes zosterVaricella-zoster virus human ganglionic latency: a current summary.Characterization of the host immune response in human Ganglia after herpes zoster.Herpes Zoster Induced Osteomyelitis in the Immunocompromised Patients: A 10-year Multicenter Study.Presentation and management of herpes zoster (shingles) in the geriatric population.Varicella-zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line.Neurovirological methods and their applications.Productive varicella-zoster virus infection of cultured intact human gangliaVaricella-zoster virus IE62 protein utilizes the human mediator complex in promoter activation.Herpes zoster: A clinicocytopathological insight.The DNA element controlling expression of the varicella-zoster virus open reading frame 28 and 29 genes consists of two divergent unidirectional promoters which have a common USF site.Opportunistic infections due to inflammatory bowel disease therapy.Necrotising herpetic retinopathies: a review and progressive outer retinal necrosis case report.Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugsShoulder pain due to cervical radiculopathy: an underestimated long-term complication of herpes zoster virus reactivation?Varicella zoster meningoradiculitis in Crohn's disease treated with 6-mercaptopurine.Herpes Zoster Induced Alveolar Bone Necrosis in Immunocompromised Patients; Two Case Reports.Herpes-zoster virus ophthalmicus as presenting sign of HIV disease.A historical perspective on the role of sensory nerves in neurogenic inflammation.Lytic Transcriptome Dataset of Varicella Zoster Virus Generated by Long-Read Sequencing
P2860
Q27687191-1E53995B-3917-4639-AB78-7B8E879F92C7Q33562824-4E6495DA-49CB-4BCA-ADC9-E8826237E2E1Q33704274-AF5F6594-AC7D-48EF-9221-7A170487DBB2Q34055440-1210441A-393F-4FCC-8EC0-209621BE2316Q34111929-877CAFF6-536C-4F86-A5CA-E3318AE3240AQ34352218-CC2E08E6-065C-4E8E-A9DC-DCA284AB2295Q34575055-CF61957D-D402-430A-96B2-D4D7D4E84F34Q35183104-D041572F-42E9-4F56-A1A6-B2F1FD763829Q35857312-80289827-4E00-4DA2-8005-A77E69E21A15Q36994683-29154EE4-1055-4942-97BA-82493A6DACA8Q37312128-489E5452-4BB1-406F-9B43-04F79E789F5CQ37567946-FA010895-9E2E-4211-9791-65E32D631F4FQ38139812-794DA07B-1CA1-4EFD-8F10-87B1BB39E7B7Q38530473-AFD3614A-F943-47CD-A4A8-47CE93BC170AQ38603800-4B837E97-2D9C-4746-8CEC-C6ABAE34E116Q38629400-2AF806F2-134F-411C-8046-9858830AF443Q39907984-7E11EB7F-26C2-4DCA-8E61-B7A8D92EA0DBQ40507592-22EFCCFA-E946-4396-8010-7F50D9149D30Q46306637-3D776998-A0D2-43EE-83EF-A011AFE6B176Q52608295-11F9C696-07EF-486B-AB8A-39B554F11215Q58553655-1DA654ED-B77A-4C03-8068-DE61B1373A60
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Varicella-zoster virus latency in human ganglia
@ast
Varicella-zoster virus latency in human ganglia
@en
Varicella-zoster virus latency in human ganglia
@nl
type
label
Varicella-zoster virus latency in human ganglia
@ast
Varicella-zoster virus latency in human ganglia
@en
Varicella-zoster virus latency in human ganglia
@nl
prefLabel
Varicella-zoster virus latency in human ganglia
@ast
Varicella-zoster virus latency in human ganglia
@en
Varicella-zoster virus latency in human ganglia
@nl
P2860
P3181
P356
P1476
Varicella-zoster virus latency in human ganglia
@en
P2093
Peter G.E. Kennedy
P2860
P304
P3181
P356
10.1002/RMV.362
P577
2002-01-01T00:00:00Z